Understanding how protein AMPylation affects protein stability and aggregation in diseases like Alzheimer's
Conserved regulation of proteostasis by post-translational protein AMPylation
This study is looking at how a special process called AMPylation helps keep proteins stable and prevents them from clumping together, which is important for understanding diseases like Alzheimer's, and it could lead to new treatments for conditions caused by protein problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10894161 on NIH RePORTER |
What this research studies
This research investigates the role of protein AMPylation in maintaining protein stability and preventing aggregation, particularly in the context of diseases such as Alzheimer's. By studying how specific enzymes, known as AMPylases, regulate this process, the research aims to uncover the mechanisms that control the aggregation of harmful proteins like amyloid-β. The approach involves using various model organisms, including the nematode C. elegans, to explore the genetics and biochemistry of protein aggregation and proteostasis. The findings could lead to new therapeutic strategies for diseases associated with protein misfolding and aggregation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease or other neurodegenerative disorders linked to protein aggregation.
Not a fit: Patients with conditions unrelated to protein aggregation or those who do not have a genetic predisposition to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help prevent or mitigate the effects of Alzheimer's disease and other protein aggregation-related conditions.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation mechanisms, suggesting that this approach could yield significant insights and advancements.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Truttmann, Matthias Christof — University of Michigan at Ann Arbor
- Study coordinator: Truttmann, Matthias Christof
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.